| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 499.67 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 304.963 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 231.22 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 506.245 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 335.326 | 88 |
| GSM780721 | Untreated after 4 days (C3_2) | 225.637 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 243.277 | 85 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 462.58 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 449.392 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 248.378 | 86 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 426.426 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 474.059 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 457.058 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 320.914 | 88 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 404.445 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 437.849 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 339.323 | 88 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 432.555 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 451.668 | 91 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 451.58 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 405.899 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 413.723 | 90 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 310.971 | 88 |